Bleeding Management

Management of Bleeding while using a NOAC2

bleeding_while_using_a_noac

                                                                                                                 Adapted from Steffel J et al. Europace. 2021 Oct 9;23(10):1612-1676

Andexanet alfa is not approved for use in India.

References: 1. Granger CB, Alexander JH, McMurray JJ, et al. Apixaban  versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11):981-992 2. J. Steffel et al. 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. Europace. 2021 Apr 25:euab065. doi: 10.1093/europace/euab065

#Ruff CT, et al. Lancet. 2014;383(9921):955-62, Hur et al, Acta Orthopaedica 2017; 88 (6): 634–641, Cohen AT et al. Adv Ther 2014;31:473-93

Disclaimer: The products discussed herein may have different product labeling in different countries. The product information provided in this site is intended only for residents of India

PP-ELI-IND-0967 28-07-2021
Please click on Prescribing Information link to view safety and adverse events information of Eliquis
For the use only of registered medical practitioner, or a hospital or a laboratory.